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Chlamydophila (Chlamydia) pneumoniae promotes 
Aβ 1-42 amyloid processing in Neuronal Cells: A Pathogenic Trigger 
for Alzheimer's Disease
Background: Previously, our laboratory identified Chlamydophila (Chlamydia) pneumoniae
(Cpn) in autopsied sporadic AD brains. Furthermore, we have developed a BALB/c mouse
model that demonstrated infection-induced amyloid plaques similar to those found in AD, and
demonstrated that Cpn infection of neuronal cells inhibited apoptotic pathways of cell death. 
Hypothesis: Our current studies address whether infection with Cpn in neuronal cells triggers
abnormal cleavage of the beta amyloid precursor protein (βAPP) into Aβ1-42, thereby con-
tributing to amyloid plaque formation characteristic of the pathology identified in AD. 
Materials and Methods: Human neuroblastoma cells were infected with the respiratory strain
AR39 Cpn in vitro, then amyloid processing was analyzed and quantitated using immunocyto-
chemistry, Western blotting and ELISA assays. 
Results: Cpn was shown to infect neuronal cells and induce intracellular amyloid processing.
Cpn infection yielded cytoplasmic labeling of Aβ 1-42 that was increased relative to uninfected
cells. The ELISA assay revealed that in neuronal cell lysates, Aβ 1-42 in the infected cells was
increased 3 to 16-fold over the uninfected cells, from 24 to 72hr post infection. Western blot
analysis confirmed an increase in Aβ 1-42 in the infected neuronal cell lysates. 
Conclusions: These data suggest that infection of neuronal cells with Chlamydophila
(Chlamydia) pneumoniae alters the processing of βAPP, thereby producing Aβ1-42. Therefore,
these studies and previous research reported by our laboratory support the implication of Cpn
as a pathogenic agent in perpetuating the hallmark amyloid plaque formations observed in AD.
This concept holds major therapeutic considerations for future studies. 
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Amyloid plaques are a pathological feature of Alzheimer's disease (AD) that are formed by the
abnormal deposition of fragments of amyloid precursor protein (APP).  Proteolysis by secretases
of APP near its carboxyl terminus leads to the generation of 40-43 amino acid peptides that
comprise beta-amyloid (Aβ) (Selkoe et al., 1988). These peptides undergo conformational
change into β-sheets that deposit into plaques in regions of the brain particularly susceptible to
this damage. This deposition appears to be critical in the neuronal degeneration observed in AD
(Schellenberg, 1995).   There is a hereditary form of the disease, called Familial AD (FAD), that
accounts for a small percentage (~5%) of total AD cases world-wide, while sporadic AD
accounts for the vast majority of AD cases (estimates of 95% or more).  Specific mutations have
been recognized in FAD that are associated with the increased proteolysis of APP to form Aβ.
However, with sporadic AD, few genetic factors have been implicated, and thus, environmental
triggers for amyloid deposition are under investigation.
Infection within the central nervous system (CNS) by Chlamydophila (Chlamydia) pneumoniae
has been suggested to play a role in sporadic AD.  In two separate studies, polymerase chain reac-
tion detected C. pneumoniae DNA in 80 - 90% of postmortem brain samples examined from
sporadic AD (Balin et al., 1998, Gerard et al., 2006), but in only 5 - 11% of postmortem brain
samples from age-matched, non-AD, control individuals.  Furthermore, a murine model has
been developed in which non-transgenic mice infected with C. pneumoniae demonstrate
deposits of amyloid in areas of the brain typically affected in AD (Little et al., 2004).
The role that C. pneumoniae plays in “triggering” events resulting in AD pathology has been fur-
ther analyzed following in vitro infection of a human neuroblastoma cell line, SK-N-MC- HTB-
10.  Experiments were designed to determine whether infection with C. pneumoniae influences
the production and/or processing of Aβ amyloid oligomers from the beta amyloid precursor
protein (βAPP), thereby associating C. pneumoniae infection with the formation of toxic
Aβamyloid species that may contribute to the pathology of Alzheimer's disease.
Immunocytochemistry, using antibodies specific for the 1-42 fragment of Aβ, suggested that
infection in neuronal cells resulted in an increase in Aβ 1-42 immunoreactive peptides.  The
results from these studies indicated that intracellular amyloid processing was induced in neu-
ronal cells infected by C. pneumoniae producing cytoplasmic labeling of 1-42 β-amyloid
oligomers.  ELISA assays revealed that in neuronal cell lysates, 1-42 β-amyloid in the infected
cells was increased 3 to 16-fold over the uninfected cells from 24 to 72 hrs post-infection,
Western blot analysis confirmed an increase in higher molecular weight (>50kDa) 1-42 β-amy-
loid in the infected neuronal cell lysates at all time points post-infection.
These data suggest that infection of neuronal cells with C. pneumoniae affects the processing of
βAPP into 1-42 β-amyloid higher molecular weight species presumably representing Amyloid
beta derived diffussible ligands (ADDLS). Therefore, these studies and previous research 
support the implication of C. pneumoniae as a pathogenic agent that can perpetuate the 
production of neurotoxic amyloid found in Alzheimer's disease.
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Tissue Culture
SK-N-MC, neuroblastoma cells (ATCC HTB-10) were cultured in minimum essential medium
(MEM) (ATCC 30-2003) containing 10% FBS and maintained at 37°C in 5% CO2. 
Infection of Cells/Chamber Slides
Chamber slides (4 wells/slide Culture Slides )(BD Falcon cat# 354114) were seeded with 1 x 105
cells/well.  Within 24 hours of seeding cells, were infected in 200µL growth media with 
C. pneumoniae AR-39 (ATCC cat # 53592) at an MOI of 1. The cells were centrifuged in a
Sorvall Legend RT at 750Xg for 30 minutes at 20°C.  The cells were incubated for 1 hour at
37°C in 5% CO2.  An additional 300µL of growth media was added to the cells and then incu-
bated for 24, 48 and 72 hours at 37°C in 5% CO2 prior to processing for immunocytochemistry.
Infection of Cells/Flasks
T25 flasks were seeded with 1 x 105 cells/mL.  The cells were infected at the time of seeding with
C. pneumoniae AR-39 at an MOI of 1. Neuronal cells were centrifuged in 3 mls of growth media
with C. pneumoniae in a Sorvall Legend RT at 750X g for 30 minutes at 20°C.  An additional
7 mls of growth media was added.  The cells were then incubated at 37°C in 5% CO2 for 24,
48, and 72 hours. 
Immunocytochemistry
Cells were rinsed with Hanks buffered salt solution (HBSS) and then fixed with cytofix/cytop-
erm (BD Bioscience, San Jose, CA cat # 554722) for 30 min. The cells were washed in phos-
phate-buffered saline (PBS) three times and then blocked in Perm Wash (BD Bioscience, San
Jose, CA cat #554723) for 30 minutes at 20°C. The slides were incubated with primary anti-
bodies in a 37∞C water bath for 1 hr, and then washed in PBS three times. For those antibod-
ies not directly conjugated, secondary antibodies were added to the slides and incubated for 1
hour in a 37∞C water bath.  Following incubation, the slides were washed in PBS and rinsed in
distilled water two times and then incubated at 20°C for 5 minutes with Bis-benzimide or
Hoechst stain (Dapi) (Sigma-Aldrich, St. Louis, MO  B2261). The slides were washed in dis-
tilled water and cover slipped with anti-fading aqueous mounting media (Biomeda cat# M01).
Image Capture
Slides were viewed on a Nikon E800 epifluorescence microscope. Images were captured with a
Spot RT camera (Diagnostic Instruments, Sterling Heights, MI) and analyzed using Image Pro
Plus 6.2 software (Media Cybernetics, Bethesda, MD).
Western Analysis 
Cells were homogenized in lysis buffer (Sigma mammalian cells lysis kit; MCL-1) or Ripa Buffer
(Thermo Scientific cat# 89901) and electrophoresed into a 10-20% gradient Tris-Tricine gel
(Cat# 161-1160 BioRad) and transferred onto 0.45um nitrocellulose (Schleicher & Schuell).
The transfers were blocked in 1% casein (Pierce cat #37352) for 30 minutes, incubated in pri-
mary antibody diluted in PBS for 2hrs at RT and then further blocked in 1% casein for 15 min-
utes at RT followed by incubation in secondary antibody diluted in 1% casein overnight at 4°C.
The transfers were rinsed in PBS for 1hr and then water.  They were developed in ECL solu-
tions (Santa Cruz) and exposed to radiographic film.
ELISA Assay
The β-Amyloid (1-42) Elisa Protocol kit (Covance-Beta mark x-42, sig-38952) was utilized for
quantitation of 1-42 amyloid in cell lysates.  The standard curve, samples, working incubation
buffer and wash buffer were prepared following a modified manufacturer's protocol.   The sam-
ples were diluted up to 100ul in working incubation buffer.  300µL of wash buffer was added
to each well and the fluid was decanted and the ELISA plate was patted dry.  100ul of each stan-
dard and 100ul of sample was added to the plate.  The plate was covered and incubated at 4°C
over night.  The contents were then removed from the plate and the wells were washed by
adding 300ul of wash buffer to each well.  This was repeated for a total of 5 times.  The detec-
tion reagent was modified for a HRP reaction and the HRP detection antibody was added to
the working incubation buffer and incubated at 4°C over night.  The wells were then rinsed with
PBS 3 times.  50ul of tetramethylbenzidine (TMB) ELISA reagent was added to each well and
incubated for 30 minutes at room temperature.  50ul/well of stop reagent was added to the
plate.  The solutions were pipetted into a clear bottom plate and read on a BioRad ELISA
Reader at 450nm.
l C. pneumoniae infection of neuronal cells was associated with increased cyto-
plasmic labeling of β1-42 amyloid 
l Western blot analysis confirmed an increase in higher molecular weight
(>50kDa) 1-42 β-amyloid oligomers in the infected neuronal cell lysates at 24
to 72 hrs post-infection
l The ELISA assay revealed in the infected cells an increase of 3 to 16-fold of 
1-42 β-amyloid over the uninfected cells from 24 to 72 hrs post-infection
Increase of β1-42 amyloid following C. pneumoniae infection implicates
this organism as a microbial trigger in the pathogenisis of AD.
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Figure 1:  Neuronal cells infected with C.  pneumoniae AR39 and immunolabeled for 1-42 β-amyloid using monoclonal antibody
6E10.  Infected neuronal cells at 24 hrs (panel B), 48 hrs (panel C), 72 hrs (panel D) displayed similar fluorescence intensity in cyto-
plasmic labeling of 1-42 β-amyloid.  The fluorescence intensity of 1-42 β-amyloid cytoplasmic labeling was diminished in the uninfect-
ed neuronal cells (panel A) relative to the infected neuronal cells.  1-42 β-amyloid polyclonal primary antibody (6E10) was labeled with
secondary anti-mouse rhodamine (alexa fluor 594) (red) chlamydial inclusions were labeled with a monoclonal 60C19 Chlamydia FITC-
conjugated antibody (green).  Nuclei were labeled with Dapi stain (blue)
Figure 3:  Quantitation of β-amyloid protein in infected/uninfected neuronal
and astrocytes cells.  The quantity of 1-42 β-amyloid is greater in the infected neu-
ronal cells than in the uninfected cells. 1-42 β-amyloid is highest at 24 hour post
infection in the neuronal cells, decreasing at 48 and 72 hours however remaining
increased compared to time-matched uninfected neuronal cells.
Figure 2:  
A. Western blot analysis of neuronal cell lysates labeled with 1-42 β-amyloid
antibody 75B. 1-42 β-amyloid is present in the uninfected and the infected neu-
ronal cells.  There is an increase of 1-42 β-amyloid in the infected AR39 neuronal
cells compared to the uninfected neuronal cells.
B.  Western blot of neuronal cell lysates labeled with CP antibody 10C27.
10C27 established the presence of CP in neuronal cells at 24, 48 and 72 hours that
have been infected at an MOI of 1.
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